A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects
Clinical trial NCT03586570 · COMPLETED
Trial details
- NCT number
- NCT03586570
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2018-09-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.